- Home
- ABM vs KNSA Comparison
ABM vs KNSA Comparison
Compare ABM & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABM
- KNSA
- Stock Information
- Founded
- ABM 1909
- KNSA 2015
- Country
- ABM United States
- KNSA United Kingdom
- Employees
- ABM N/A
- KNSA N/A
- Industry
- ABM Diversified Commercial Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ABM Finance
- KNSA Health Care
- Exchange
- ABM Nasdaq
- KNSA Nasdaq
- Market Cap
- ABM 2.8B
- KNSA 2.6B
- IPO Year
- ABM N/A
- KNSA 2018
- Fundamental
- Price
- ABM $43.07
- KNSA $42.58
- Analyst Decision
- ABM Strong Buy
- KNSA Strong Buy
- Analyst Count
- ABM 3
- KNSA 6
- Target Price
- ABM $55.67
- KNSA $51.33
- AVG Volume (30 Days)
- ABM 525.0K
- KNSA 367.8K
- Earning Date
- ABM 12-17-2025
- KNSA 10-28-2025
- Dividend Yield
- ABM 2.47%
- KNSA N/A
- EPS Growth
- ABM N/A
- KNSA N/A
- EPS
- ABM 1.84
- KNSA 0.47
- Revenue
- ABM $8,627,900,000.00
- KNSA $597,973,000.00
- Revenue This Year
- ABM $5.43
- KNSA $61.60
- Revenue Next Year
- ABM $3.15
- KNSA $30.76
- P/E Ratio
- ABM $23.31
- KNSA $91.12
- Revenue Growth
- ABM 4.27
- KNSA 55.68
- 52 Week Low
- ABM $40.00
- KNSA $17.82
- 52 Week High
- ABM $57.93
- KNSA $42.98
- Technical
- Relative Strength Index (RSI)
- ABM 50.66
- KNSA 67.28
- Support Level
- ABM $41.56
- KNSA $40.44
- Resistance Level
- ABM $43.52
- KNSA $42.98
- Average True Range (ATR)
- ABM 0.89
- KNSA 1.43
- MACD
- ABM 0.28
- KNSA 0.15
- Stochastic Oscillator
- ABM 84.80
- KNSA 90.82
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.